Best of WCLC 2025 SFO | ALK, ROS1, and BRAF Positive Lung Cancer

Best of WCLC 2025 SFO | ALK, ROS1, and BRAF Positive Lung Cancer

Overview

NA

Target Audience

Physicians
Nurses
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Jonathan Riess, MD, MS

Date of Release

October 17th, 2025